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Background: Thymus algeriensis Boiss. et Reut. (Lamiaceae), popularly known as “mougecha” or “mazoukcha” is
prolific in Mediterranean regions, mostly in North Africa, and is used in folk medicine to treat of stomach diseases.
Methods: In this study, animals were induced with gastric ulcers using HCl/ethanol (0.3 M HCl/60% ethanol) and
treated orally with essential oil of Thymus algeriensis (EOTa) in various doses ranging from 54 mg/kg body weight to
180 mg/kg body weight.
Result: The dose found to be effective was 180 mg/kg body weight, since this dose brought about a maximum
reduction in lesion index in female rats. In gastric tissues, levels of total glutathiones (GSH, GST and GPx) and
thiobarbituric acid reactive substances (TBARS) were evaluated. The activities of the antioxidant enzymes, catalase
(CAT) and superoxide dismutase (SOD) were measured. Histopathological changes were observed using a cross
section of gastric tissue. Chemical analysis revealed the presence of 13 components accounting for 77.7% of the
essential oil from dried leaves. Oral administration of EOTa (54, 117 and 180 ml/kg) inhibited HCl/ethanol-induced
ulcers. Lesion index was significantly reduced in ulcer induced animals treated with EOTa (HCl/ethanol + EOTa)
compared to those ulcerated with HCl/ethanol but with no treatment given. Females showed a greater resistance
to ulcers and gastric lesions occurred less often than in males. GSH, pH, enzymic antioxidants, and adherent mucus
content were all significantly increased.
Conclusion: From the data presented in this study, it can be concluded that male rats are more sensitive to gastric
ulcers induced by HCl/ethanol than females.
Keywords: Thymus algeriensis, Gastric ulcers, HCl/ethanol, Antioxidant enzymesBackground
A peptic ulcer is an excoriated area of the gastric or duo-
denal mucosa caused by gastric juice action. It is both a
chronic and recurrent disease, and the most predominant
of the gastrointestinal diseases [1]. Potentially injurious
agents such as acid, pepsin, bile acids, food ingredients,
bacterial products and drugs have been implicated in the
pathogenesis of gastric ulcers, including increased gastric
acid and pepsin secretion, decreased gastric blood flow,
suppression of endogenous generation of prostaglandins,* Correspondence: fguesmi77@yahoo.com
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unless otherwise stated.inhibition of mucosal growth and alteration of gastric mo-
bility [2]. Some evidence suggests that reactive oxygen
species play a role in the etiology and pathogenesis of di-
gestive system disorders such as gastrointestinal inflam-
mation and gastric ulcers [3].
ROS could either directly disrupt the mitochondrial
membrane that subsequently leads to the release of cyto-
chrome C which becomes a part of the apoptosome com-
plex, or it could lead to membrane rupture of lysosomes
in an additive way resulting in the release of cathepsins
which activate caspase and an apoptosis cascade, finally
leading to cell death via apoptosis. On the contrary, cells
protect themselves against the destructive effects of ROS
by scavenging them through the enzyme defense system,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[4]. After exposure to oxidative stress, the defense mecha-
nisms including an enzymatic system such as superoxide
dismutase (SOD), catalase (CAT), glutathione peroxidase
(GPx) and non-enzymatic system such as glutathione
(GSH), β-carotene (vitamin A), ascorbic acid (vitamin C)
and α-tocopherol (vitamin E) are involved [5,6].
The stomach can activate many gastroprotective mecha-
nisms to prevent injury from noxious agents. Of these de-
fensive factors, several studies have recently demonstrated
that the gastric mucus offers protection [7,8]. When it is
overwhelmed or breaks down due to disease, the second
line of defense includes intracellular acid neutralization,
rapid epithelial repair and maintenance, and redistribution
of gastric vasculature [9].
The current medicinal treatment of peptic ulcers is gen-
erally based on inhibition of gastric acid secretion by H2-
blockers, omeprazole and antimuscarinics, as well as on
acid-independent therapy provided by sucralfate and bis-
muth. The first proton pump inhibitor (PPI) used clinically
was omeprazole (2-[[3,5-dimethyl-4-methoxypyridin-2- yl]
methylsul®nyl]-5-methoxy-1H-benzimidazole). Compounds
in this class are acid-activated prodrugs [10]. In cases of
Helicobacter pylori infection, antibiotics are used. Obvi-
ously, drugs endowed with antisecretory activity coupled
with gastroprotective effects could be a promising ap-
proach for successful treatment of peptic gastric ulcers be-
cause of the potential complementary effects of therapeutic
modalities acting via different mechanisms [11].
It has been suggested that experimental ulcers induced
by ethanol administration cause more severe gastric ero-
sion in male rats than in females [12]. The female sex has
a greater resistance to stress and thus, gastrointestinal le-
sions happen less often than in the male sex [13]. Males
have a well-known risk of stroke and, in most epidemio-
logical series, stroke occurs more frequently in men than
women. This sexually dimorphic disease pattern remains
apparent until an age well beyond the menopausal years
[14]. The development of new antiulcer drugs and the
search for novel molecules has therefore been extended to
herbal drugs that offer better protection and decreased re-
lapse. Medicinal plants provide an effective and safer way
to manage disease. Many medicinal plants exhibit antiul-
cer activity and were found useful in the treatment of pep-
tic ulcers [15].
Generally, antiulcerogenic compounds obtained from
plants exert their effects either by stimulating the protect-
ive factors of gastric mucosa due to increased synthesis of
prostaglandins, by stimulating the secretion of mucus and
bicarbonate through inhibition of acid secretion by inter-
acting with different receptors, or by regulating enzymes
or hormones involved in the secretory process [16].
Herbal medicines have now triumphed as a diverse popu-
lar therapy and are emerging as an alternative treatment tothe synthetic drugs available [17,18]. The latest trends have
shown an increasing demand for phytodrugs and some me-
dicinal herbs have been proven to have antiulcer activity.
This alone is an important reason to investigate the antiul-
cer effects of medicinal plants through traditional use in
preventing gastric disease. Essential oils are an important
part of traditional pharmacopoeia in many countries and
have been successfully used for gastroprotection and heal-
ing ulcers. Essential oils are complex mixtures made up of
many single compounds chemically derived from terpenes
and their oxygenated compounds. These constituents con-
tribute to the antifungal, antiviral and antioxidant effects
[19,20]. Of those plants known for their medicinal value,
the plants of the genus thymus belonging to the Lamiaceae
family (common name: Mougecha or Mazoukcha) are very
important for their therapeutic potential. Thymus alger-
iensis, which is commonly found throughout North
Africa, has been widely used in traditional medicine as an
antiseptic and antispasmodic. Furthermore, this plant also
has widespread use in folk medicine against illnesses of
the digestive tube and for antiabortion [21]. Recently, T.
algeriensis essential oil was found to possess an interesting
inhibitory activity towards the angiotensin I-converting
enzyme suggesting the potential of this plant as an antihy-
pertensive agent [22].
Thus, the present study intends to explore the ulcero-
protective and antioxidant activity of the essential oil of
this species on HCl/ethanol- induced ulcers in rats. Our
aim was to investigate whether sex had an influence on
healing changes in the gastric acid secretion and blood
flow at the margin of the ulcer.Material and methods
Plant material
The aerial part of Thymus sp. algeriensis was collected
on Mount Orbata (Jbel Orbata) near Zannouch, Gafsa,
Tunisia. No specific permission was required to take
plants from these locations and the field studies did not
involve endangered or protected species. The plant ma-
terial was authenticated by Mr. Hamdi Lazhar, Engineer
and Director of Bouhedma Natural Park and the vou-
cher specimens were deposited in the Herbarium of the
National Institute of Agronomy of Tunisia (INAT) for
future reference.Extraction and chromatographic analysis of the essential
oil of Thymus algeriensis (EOTa)
The essential oil from dried powdered Thymus algerien-
sis aerial parts was isolated by steam distillation in a
Clevenger-type apparatus according to Procedure III of
the Yugoslav Pharmacopoeia IV [23]. Essential oil yield
was 2.3% (w/w). Freshly isolated essential oil was a yel-
low liquid with an intense, necrotic odor.
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to analysis by GC-MS. GC analysis was performed on a
model 7890 A (series II) gas chromatograph, with a flame
ionization detector (FID) and a split ratio of 1:50 using a
fused silica capillary column, HP5-MS (30 m× 250 μm i.d.,
0.25 μm film thickness). Injector or detector temperature
for each analysis was about 250°C, and the carrier gas was
helium with a flow rate of 0.8 ml/min. Peak areas were
measured by electronic integration, and relative amounts
of the individual components were based on the peak
areas. GC-MS was carried out on an Agilent model 5975 C
mass spectrometer operating at ionizing energy mode at
70 eV, combined with the GC described above.
Preparation of drug solution
One hundred grams of the air dried AERIAL PART OF
Thymus algeriensis were steam distilled for 6 h to prepare
the appropriate stock solution of the drug, i.e. 54 mg/ml,
117 mg/ml and 180 mg/ml. Complete analyses of the sam-
ples are in progress. For the pharmacological tests carried
out here, the complete essential oil was emulsified in ve-
hicle (0.1% Tween 80 aqueous solution) before adminis-
tering it to the animals. The doses were administered
orally by selecting the appropriate concentration of the
stock solution. Omeparazole was dissolved in vehicle and
given orally to the reference control group (6 rats) in
doses of 20 mg/kg body weight.
Experimental protocol
A total of 54 Adult male and female Wistar rats (weighing
150 to 180 g and housed six per cage) were obtained from
the Animal Laboratory of the Pasteur Institute of Tunis,
Tunisia (Ethics No. LNSP/Pro 152012). They were pro-
vided with food and water ad libitum and were housed in
polypropylene cages under pathogen free, uniform condi-
tions of light and dark cycles (12 h each). Temperature
was kept constant at 25°C ± 2°C. Rats were randomly di-
vided into 9 groups (n = 6/group) and made to fast for
24 h with free access to water prior to the experiment.
Group 1 (Female rats) and Group 2 (Male rats): theTable 1 The experimental design and specifications
Groups number Description Pre-treat
Group 1 Control (female rats) 0.5 ml of
Group 2 Control (male rats) 0.5 ml of
Group 3 Reference control Omeprazo
Group 4 Experimental group 1 (male rats) Complex
Group 5 Experimental group 2 (male rats) Complex
Group 6 Experimental group 3 (male rats) Complex
Group 7 Experimental group 4 (female rats) Complex
Group 8 Experimental group 5 (female rats) Complex
Group 9 Experimental group 6 (female rats) Complexanimals were given an oral dose of 0.5 ml of vehicle (0.1%
tween-80 aqueous solution) (Table 1); 80 mg/ml of a solu-
tion containing 0.3 M HCl/60% ethanol (HCl/ethanol) to
induce gastric ulcers was administered overnight to fasting
rats. Group 3: (Standard drug treated group): rats were
treated with omeprazole (20 mg/kg/p.o) one hour before
they were subjected to the HCl/ethanol treatment. Groups
4, 5, and 6 received EOTa (54, 117 and 180 ml/kg, p.o
treated female rats) and Groups 7, 8 and 9 received EOTa
(54, 117 and 180 ml/kg, p.o treated male rats) treated with
essential oil of T.algeriensis dissolved in a 0.1% tween
80% aqueous solution. HCl/ethanol (80 mg/ml) was ad-
ministered after one hour to induce ulcers. Animals
were sacrificed 1 h after administering HCl/ethanol and
the stomachs were excised and inflated by saline injec-
tion (2 ml) to determine the ulcer index. All rats were
sacrificed under ether anesthesia, and all efforts were
made to minimize suffering. Throughout the experiments,
all animals were treated humanely. All experiments were
performed in the morning and in accordance with the
guidelines provided by the Institutional Animal Ethics
Committee. The gastroprotective effect of EOTa was
assessed from lipid peroxide (LPO), reduced glutathi-
one (GSH), and activities of enzymic antioxidants—
super oxide dismutase (SOD), catalase (CAT), glutathione
peroxidase (GPx), and glutathione-S-transferase (GST) in
gastric mucosa.
Macroscopic gastric lesion evaluation
After washing with normal saline, gastric lesions were
quantified and ulcers were scored according to the method
used by Dashputre and Naikwade [24]. The ulcer scores
were as follows:






vehicle (0.1% tween-80 aqueous solution) (80 mg/ml) HCl/ethanol
vehicle (0.1% tween-80 aqueous solution) (80 mg/ml) HCl/ethanol
le 20 mg/kg (80 mg/ml) HCl/ethanol
54 mg/kg (80 mg/ml) HCl/ethanol
117 mg/kg (80 mg/ml) HCl/ethanol
180 mg/kg (80 mg/ml) HCl/ethanol
54 mg/kg (80 mg/ml)HCl/ethanol
117 mg/kg (80 mg/ml)HCl/ethanol
180 mg/kg (80 mg/ml)HCl/ethanol
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an ulcer index. The percentage of ulcer protection was de-
termined as follows:
The ulcer index score for each animal was expressed as
an ulcer index. The percentage of ulcer protection was de-
termined as follows:
The ulcer index (UI) was measured using following
formula:
UI = UN +US + UP × 10− 1 Where, UI = Ulcer Index;
UN =Average number of ulcers per animal;
US = Average severity score; UP = Percentage of ani-
mals with ulcers.
The mean ulcer score for each animal was expressed
as an ulcer index. The percentage of ulcer inhibition was
determined as follows:
% inhibitionof Ulceration ¼ Ulcer indexControl−Ulcer indexTestð Þ
Ulcer indexControlð Þ  100
Histology of gastric lesions
Samples of gastric tissue were fixed in 10% buffered for-
malin. The stomach was sectioned at 5 μm and stained
with Hematoxylin Eosin for histological assessment.
Assessment of oxidative stress in tissue
In order to determine the effect of EOTa on oxidative
stress induced in the HCl/ethanol model, the levels of
GSH, TBARS and activities of SOD, CAT, GPx and GST
were measured in gastric tissue.
Preparation of homogenate
The stomachs were weighed and homogenized in a buf-
fer solution of potassium phosphate (pH 7.4) and centri-
fuged at 3,000 rpm/15 min. The supernatant was used
for the enzymatic and MDA assays.
Estimation of protein
Protein content of the gastric tissue was determined by
the Folin Lowry Method using a bovine serum albumin
as a standard [25].
Determination of total glutathione (GSH)
Reduced glutathione was estimated by the method indi-
cated by Sedlak and Lindsay [26]. The homogenate was
immediately precipitated with 0.1 ml of 25% trichloroacetic
acid, and the precipitate was removed by centrifugation at
4200 rpm for 40 min at 4°C. The precipitated tissue hom-
ogenate was treated with 5,5′-dithiobis(2- nitrobenzoic
acid) (DTNB) reagent. A standard calibration curve was
prepared using reduced glutathione (GSH). Absorbance
was measured at 412 nm using a spectrophotometer. The
amount of glutathione was expressed as μmol/mg protein.Estimation of SOD antioxidant enzyme
Enzyme activity was assayed by following the inhibition of
pyrogallol auto-oxidation [27]. Pyrogallol (24 mmol/L)
was prepared in 10 mmol/L HCl and stored at 4°C. CAT
30 μmol/L stock solution was made in an alkaline buffer
(pH 9.0). Aliquots of supernatant were added to a Tris–
HCl buffer containing 12.5 μl of pyrogallol and 12.5 μL of
CAT stock solutions. The total reaction mixture was made
to 1.425 ml with the same Tris–HCl buffer. Auto-
oxidation of pyrogallol was monitored by measuring ab-
sorbance at 420 nm at 1-minute intervals for 5 minutes.
SOD activity was determined from a standard curve of
percentage of inhibition of pyrogallol auto-oxidation with
a known SOD activity. One unit of SOD is defined as the
amount that shows 50% inhibition at room temperature
and a pH of 7.8.Estimation of catalase (CAT) activity
5 ml solution of 0.01 M hydrogen peroxide was prepared
with the buffer solution and used as a substrate for the
assay. 20 μl of the supernatant sample was mixed with
780 μl of buffer/hydrogen peroxide and 200 μl of distilled
water. The enzyme activity was measured at 240 nm by
spectrophotometry for 60 s by reading the change in ab-
sorbance between the fifteenth and sixtieth second. The
results are expressed in μmol H2O2/min/mg of protein
[28].Estimation of GST activity
GST was assayed with the method used by Habig [29]
by adding 1-chloro-2,4-dinitrobenzene (CDNB). Change
in optic density was read at 340 nm for 3 min at an
interval of 30 s. The GST activity was expressed as nmol
of CDNB conjugate formed/min/mg protein.Estimation of GPx activity
GPx activity was measured using a modified version of
that used by Hafeman [30]. The reaction mixture con-
tained GSH, phosphate buffer, H2O2, TCA (trichloroacetic
acid), Na2HPO4 and DTNB (5, 5
′-dithiobis (2-nitroben-
zoic acid)). The rate of reaction was measured by the de-
crease in GSH, which was determined by measuring the
reaction products of DTNB and GSH (absorbance of the
ions at 412 nm). One unit of enzyme activity was defined
as a decrease of 1 μmol/L of GSH concentration at 37°C
and pH 6.5, while non-enzymatic reactions were excluded.Estimation of lipid peroxide
Lipid peroxide content in gastric mucosal tissues was
determined by thiobarbituric acid reaction as described
by Ohkawa [31]. The lipid peroxide concentration was
expressed as nmol MDA/mg protein.
Figure 1 Chromatographic profile of EOTa using gas chromatography coupled to a mass spectrometer.
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The gastric mucosa of each rodent was gently scraped
using a glass slide and the mucus obtained was weighed
using a precision electronic balance [32].
Acute toxicity study in rodents
Adult male and female Wistar Dawley rats (6–8 weeks
old; 150–180 g) were obtained from the Experimental
Animal House, Pasteur Institute, University of Tunisia.
The rodents were given standard pellets as food and
clean tap water. Thirty six rats were assigned to six
groups of six rats each. The female rats were dividedTable 2 Chemical composition of essential oils extracted from
NO. RTa RIb Componentsc
1 7.481 1017 α –terpinene
2 7.705 1025 ρ-cymene
3 7.899 1031 1,8-cineole
4 8.683 1060 γ-terpinene
5 9.576 1089 Terpinolene
6 9.919 1098 Linalool
7 11.378 1146 Camphor
8 12.431 1176 4-carvomenthenol
9 15.956 1289 Bornyl acetate
10 23.142 1511 γ-cadinene
11 25.054 1578 Spathulenol
12 25.197 1582 Caryophyllene oxide
13 25.471 1590 Viridiflorol
aRT (retention time), bRI (retention index) measured relative to n-alkanes (C10 –C15);
cCo
eGC-MS: identification based on a high match of mass spectra retention; fRI Identified
# = Chemical Abstracts service reference number compared with those reported in theinto control, low dose and high dose groups and the
same approach was taken for the males. The rodents
fasted overnight, then were given doses of EOTa at 300
and 500 mg/kg body weight, and continued fasting for
3–4 h after dosing every day for 14 days. Behavioral
changes, weight, consumption of food and water, clinical
signs of toxicity, and mortality were recorded daily [33].
Statistical analysis
The values were reported as mean ± S.E.M. The signifi-
cance (p < 0.05) of the results was assessed by one-way
analysis of variance (ANOVA), followed by Bonferroni’sThymus algeriensis using analysis by GC-MS














mponents listed in order of their retention index on HP-5 column, dPlant codes;
by retention index and compared with those reported in the literature [37]; gCAS
literature [38].
Figure 2 (See legend on next page.)
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Figure 2 Histological sections of liver and kidney from the acute toxicity test. Female rats (1a and 1b): Control group; female rats (1c and
1d): treated with 300 mg/kg of EOTa; female rats (1e and 1f) treated with 500 mg/kg of EOTa; male rats (1g and 1h): control group; male rats
(1i and 1j): treated with 300 mg/kg of EOTa; male rats (1k and 1l) treated with 500 mg/kg of EOTa. There is no significant differences in the
structure of liver and kidney between treated and control groups (Hematoxylin & Eosin stain 20 ×magnifications).
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test.Results and discussion
In this investigation, GC/MS analysis made it possible to
identify 13 compounds in EOTa, which accounting for
77.75% of the total oil content. The chromatogram in
Figure 1 shows four main components in EOTa (Table 2):
Linalool (18.05%), Camphor (13.03%), 4-carvomenthenol
(11.2%) and Viridiflorol (11.71%). Extraction procedures
for EOTa resulted in a yield of 2.36%. Previous chemical
reports of the essential oil obtained from 14 Tunisian nat-
ural populations of Thymus algeriensis leaves collected
from different geographical regions revealed that the
major components were 1,8-cineole (17.7%), α-pinene
(15.5%), and camphor (8.2%) [34]. Zouari et al. [35] found
that the major compounds of 8T. algeriensis populations
analyzed were α-pinene (7.41-13.94%), 1,8-cineole (7.55-
22.07%), cis-sabinene hydrate (0.10-12.95%), camphor
(1.55-11.86%), terpenyl acetate (0–14.92%) and viridiflorol
(0–11.49%). In terms of its phytochemical constituents,
Thymus algeriensis generally contains major classes of sec-
ondary metabolites such as flavonoids, phenolic com-
pounds and triterpenoids, to name but a few. The presence
of secondary products in fairly high concentrations has
commonly been used to explain the claimed curative and
palliative efficacy of a variety of traditional herbal medi-
cines and the reports of profound beneficial effects of cer-
tain foodstuffs on health [36]. This finding contributed to
the antiulcer pharmacological validation of this species,
lending more credence to clinical applications for the trad-
itional treatment of stomach complaints symptomatic of
peptic ulcer disease.
The equilibrium between the therapeutic versus toxi-
cological effects of a drug is a vital parameter in asses-
sing its applicability in relation to pharmacological action
[39]. As a part of this pharmacological study, EOTa was
investigated for its acute and general toxicity in rodents.
In the acute toxicity study, EOTa at doses of 300 and
500 mg kg−1 exhibited no signs of toxicity. Anatomical re-
sults showed an absence of abnormal organic damage to
the rats’ organs.
Neither female nor male rats experienced any toxicity
or mortality and there were no abnormal physiological
or behavioral changes, nor alterations in body weight at
any time during the 14 days of observation (Figure 2 and
Figure 3). Histological examination of the liver and kidneydid not show any difference compared to the control
group.
EOTa treatment (54–180 mg/kg, p.o.) caused a dose-
dependent reduction in HCl/ethanol-induced gastric
lesions, decreasing the ulcer index and percentage of in-
hibition mainly at doses of 180 mg/kg for male rats
(88%) and between 117 and 180 mg/kg for female rats
(96.25 and 98.85%) (Table 3). In this study, omeprazole
can protect the gastric mucosa against HCl/ethanol-in-
duced ulceration (65.95%).
The results of antiulcerogenic activity of EOTa on
gastric ulcers induced by the HCl/ethanol solution are
shown in Figure 4. The acidity of the gastric content in ex-
perimental animals pretreated with EOTa (female rats)
was decreased significantly compared to that of the ulcer
control group (p < 0.05). The mucus production of gastric
mucosa (Table 3) also increased significantly (p < 0.05) in
male rats treated with 180 mg/kg and female rats (117
and 180 mg/kg) compared to the ulcer control group.
Oral administration of the damaging agent to the con-
trol group clearly produced mucosal damage characterized
by multiple hemorrhage red bands of different sizes along
the long axis of the glandular stomach as described in
other studies [40,41].
Excessive acidified ethanol ingestion is an etiological
factor that gives rise to gastritis characterized by muco-
sal edema, sub-epithelial hemorrhage, cellular exfoliation
and inflammatory cell infiltration [42].
Pretreatment with EOTa (117 ml/kg and 180 ml/kg) sig-
nificantly reversed these changes for female rats (Figures 4
and 5). Stomachs of male and female rats treated with a
higher dose of EOTa showed only mild congestion; other-
wise, stomach appearance was normal. There was a clear
change in the gross appearance of the gastric mucosa
compared to the acidified treated group. Hence, it is likely
that the anti-ulceration mechanism of EOTa is due to its
antioxidant effect.
In addition, administratering EOTa to female rats was
shown to decrease the acidified ethanol-induced gastric
ulceration. The mechanism of this protective effect in-
cludes the modulatory role of female hormones on vascu-
lar permeability and an increase in mucus secretion [43].
In another report, both progesterone and estrogens atten-
uated the area of acute gastric lesions induced by aspirin
and indomethacin [44]. In contrast, testosterone-induced
delays in ulcer healing involves the fall in gastric microcir-
culation at the margin of lingual and gastric ulcers and the
excessive production and release of proinflammatory
Figure 3 Body weight gain in rats treated orally with vehicle, Thyme (EOTa, 300 mg/kg), and Thyme (EOTa, 500 mg/kg) for 15 days.
Results are mean ± SEM, n = 6. ANOVA, P > 0.05 between groups in the same day. (a) for male rats and (b) for female rats.
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accelerated ulcer healing and increased the gastric and lin-
gual blood flow at the margin of these ulcers [43].
Our results revealed the protection of the gastric mu-
cosa and inhibition of leukocyte infiltration into the gas-
tric wall in rats pretreated with EOTa. Activation and
infiltration of neutrophils appear to be involved in the
initial process that forms the lesions [45]. Neutrophil ac-
cumulation in gastric mucosa has been shown to induce
microcirculatory abnormalities [46]. The present study
established that pretreatment with EOTa reduced neu-
trophil infiltration into ulcerated tissue.
The formation of gastric mucosal lesions by necrotizing
agents such as HCl and EtOH has been reported to in-
volve the depletion of gastric defensive mechanisms [47].
Of all these changes, the most prominent are increased
capillary permeability and production of free radicals
[48], which attack and damage cell membranes, attract
neutrophils and initiate an inflammatory response [49].Table 3 Measurement of the total no. of ulcers, ulcer index, in
Groups number Treatment (p.o) PH Mucus productio
(μg/g wet tissue)
Group 1 Control (FRa) 2.7 ± 0.65* 0.85 ± 0.52*
Group 2 control (MRb) 2.95 ± 0.21* 0.43 ± 0.14*
Group 3 Omeprazole 4.37 ± 0.32# 1.2 ± 0.20#
Group 4 EOTa (MR) 3.1 ± 0.80*# 0.42 ± 0.40*#
Group 5 EOTa (MR) 3.42 ± 0.87*# 0.8 ± 0.20*#
Group 6 EOTa (MR) 5.79 ± 0.22*# 2.2 ± 0.80*#
Group 7 EOTa (FR) 5.13 ± 0.26*# 2.55 ± 0.32*#
Group 8 EOTa (FR) 5.88 ± 0.20*# 2.85 ± 0.46*#
Group 9 EOTa (FR) 6.14 ± 0.38*# 3.18 ± 0.72*#
aFR: Female Rats; bMR: Male Rats; All values are expressed as mean 6 standard error
Dunnett’s test). *significant when compared to the ulcer control groups (a and b). #sThis was further substantiated by histological findings
where a marked reduction in gastric mucosal damage and
cellular influx was observed. Some consistent treatment-
related histopathological abnormalities were found in rats
of either sex. These results indicated that EOTa exhibited a
protective effect against HCl/Ethanol-induced ulcerogen-
esis in rats. Omeprazole, on the other hand, was effective
in alleviating oxidative stress in the HCl/Ethanol model.
Omeprazole is the first of a new class of drugs that inhibit
gastric secretion by altering the activity of H+/K+-ATPase
[50,51]; it is not charged and can cross cell membranes
[52]. Due to being a weak base, omeprazole accumulates in
the acidic space of the parietal cell and, by acid-catalyzed
rearrangement, becomes a thiol-reactive cationic sulfenic
acid and/or sulfenamide that binds to cysteinyl-SH groups
to form disulfides [10].
The levels of lipid peroxidation products, GSH and ac-
tivities of enzymic antioxidants in gastric mucosa of experi-
mental animals are tabulated in Table 4. HCl/ethanol inhibition percentage, mucus and pH
n Total no. of ulcers
(mean ± SD) (n = 6)
Ulcer index
(mean ± SD) (n = 6)
% ulcer inhibition
14 ± 2.20* 17 ± 1.80* 0.00*
16.5 ± 4.20* 23.5 ± 7.30* 0.00*
5 ± 2.10# 8 ± 6.13# 65.95#
13 ± 0.70*# 14.83 ± 1.70*# 36.90*#
10 ± 1.80*# 11.42 ± 3.80*# 51.40*#
1.5 ± 0.32*# 2.82 ± 2.21*# 88.00*#
3.5 ± 2.70*# 5.3 ± 1.67*# 77.44*#
0.84 ± 1.33*# 0.88 ± 0.22*# 96.25*#
0.25 ± 0.05*# 0.27 ± 0.93*# 98.85*#
mean. Mean difference is significant at the p < 0.05 level (ANOVA followed by
ignificant when compared to the reference control group (c).
Figure 4 Gross appearance of the gastric mucosa in rats. (a) stamach of control (FR). Severe injuries are seen in the gastric mucosa (hemorrhagic
necrosis of gastric mucosa). (b) stomach of control (MR). Severe injuries are seen in the gastric mucosa (hemorrhagic necrosis of gastric mucosa). (c)
stomach of rats pre-treated with omeprazole (20 mg/kg). Moderate injuries are seen in the gastric mucosa. (d) stomach of female rat pre-treated with EOTa
(54 mg/kg). Mild injuries can be seen in the gastric mucosa. (e) stomach of female rat pre-treated with EOTa (117 mg/kg). Very mild injuries can be seen in
the gastric mucosa. (f) stomach of female rat pre-treated with EOTa (800 mg/kg). No injuries can be seen in the gastric mucosa instead flattening of gastric
is visible (white arrow). (g) stomach of male rat pre-treated with EOTa (54 mg/kg). Severe injuries can be seen in the gastric mucosa. (h) stomach of male
rat pre-treated with EOTa (117 mg/kg). Severe injuries can be seen in the gastric mucosa. (i) stomach of male rat pre-treated with EOTa (180 mg/kg). Very
mild injuries can be seen in the gastric mucosa instead flattening of gastric mucosa is visible (white arrow).
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http://www.lipidworld.com/content/13/1/138female rats (180 mg/kg) significantly increased ulceration
with a concomitant decrease in LPO levels (0.019 ±
0.09 mmol/mg vs 0.190 ± 0.02 and 0.224 ± 0.02 mmol/mg,
P < 0.001) while SOD (178.66 ± 0.01 U/mg protein vs 17 ±
0.045 and 15.38 ± 0.06 U/mg protein, P < 0.001), GSH
(3.798 ± 0.23 μmol/mg protein vs 0.085 ± 0.84 0.050 ±
0.00 μmol/mg protein, P < 0.001), GPx (6.1 ± 0.75 μmol
GSH/mg protein/ml vs 1.82 ± 0.54 and 1.25 ± 0.09 μmol
GSH/mg protein/ml, P < 0.001), GST (9.07 ± 0.72 nmol/
min/mg protein vs 0.9 ± 0.67 and 0.82 ± 0.02 nmol/min/mg
protein, P < 0.001) and CAT (20.24 ± 0.08 μmol H2O2 con-
sumed/min/mg protein vs 2.13 ± 0.33 and 2.49 ± 0.87 μmol
H2O2 consumed/min/mg protein, P < 0.001) levels were
markedly increased compared to the disease control in gas-
tric mucosal homogenate. In this study SOD, CAT, GPx,GST & GSH activities were significantly elevated by the
administration of EOTa to treat rats, suggesting that it has
the ability to restore these enzymes.
The increase in LPO may suggest a possible mechanism
of tissue injury by reactive oxygen intermediates [53]. Hy-
droxyl radicals thus generated oxidize important cellular
constituents such as structural and functional proteins,
and membrane lipids as well as deplete glutathione. Lipid
peroxidation causes loss of membrane fluidity, impaired
ion transport and membrane integrity and finally loss of
cellular functions [54].
Further, it was observed that in HCl/ethanol- adminis-
tered rats there was increased generation of reactive oxy-
gen species estimated by increased level of TBARS and
attenuated levels of GSH, as well as SOD, CAT and GPx
Figure 5 Photomicrographs of gastric mucosa (Hematoxylin-Eosin staining: magnification 20× for a, b, d, e, g, i, j and l; 40× for c, f, h,
k and m). (a) micrograph of female rats pretreated with HCI/ethanol (ulcer control group), there is epithelial exfoliation and extensive edema
(ede) of submucosa layer with distorted glands; (b, c) micrograph of male rats pretreated with HCI/ethanol (ulcer control group) shows
discontinuity in the lining epithelium with exudates in the lumen submucosal edema (ede) of submucosa layer with distorted glands. (d)
Omeprazole groups showing epithelium and submucosa with normal characteristics. The EOTa, at 54 mg kg −1 (e, f), 117 mg kg-1 (g,h) and
180 mg kg−1 (i) (for FR) showign mocosal regeneration with exudates in lumen with some inflammatory cells, mild mucosal damage, mild
leukocyte infiltration, and mild submucosal edema. The EOTa, at 54 mg kg −1 (j, k) and 117 mg kg −1 (l) (for MR) showign clearly mucosal
hemorrage, submucosal edema, leukocyte and neutrophil infiltration, inflammatory cell and abundant neutrophils, but The EOTa, at 180 mg kg −1
(m) showing clearly moderate mucosal damage and moderate submucosal edema.
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mucus (Figure 6) which was reversed in EOTa 180 treat-
ment groups. A significant decrease in gastric GSH fol-
lowing HCl/ethanol administration indicated massive
generation of free radicals. Our results corresponded
with earlier reports showing a depletion of sulfhydryls in
ethanol-induced gastric lesions [55]. Treatment with
EOTa produced a significant increase in the level of
GSH and activities of SOD, CAT, GPx and GST, and asignificant decrease in the level of TBARS in the HCl/
ethanol model (Table 4). Reduced glutathione is one of
the most abundant non-enzymatic antioxidant bio-
molecules present in the tissues [56]. Its functions are
removing free oxygen species such as H2O2, superoxide
anions and alkoxy radicals, maintaining membrane pro-
tein thiols and acting as a substrate for GPx and gluta-
thione S- transferase (GST) [57]. The non-availability of
GSH decreases the activities of GSH- dependent





























2.13* ± 0.33 1.82* ± 0.54 0.9* ± 0.67
Group
2




2.49* ± 0.87 1.25* ± 0.09 0.82* ± 0.02
Group
3




11.15# ± 0.72 4.82# ± 0.68 6.44# ± 0.05
Group
4




8.94*# ± 0.02 1.81*# ± 0.19 0.84*# ± 0.04
Group
5




4.25*# ± 0.80 2.22*# ± 0.66 1.02*# ± 0.08
Group
6




19.68*# ± 0.40 4*# ± 0.05 4.96*# ± 0.37
Group
7




11.46*# ± 0.90 3.8*# ± 0.78 6.93*# ± 0.57
Group
8




18.31*# ± 0.10 5.82*# ± 0.98 7.24*# ± 0.73
Group
9




20.24*# ± 0.08 6.1*# ± 0.75 9.07*# ± 0.72
This experiment consists of the control (FR) (Group 1), the control (MR) (Group 2), the reference group pretreated with 20 mg kg−1 of omeprazole (Group 3), the experimental
groups MR (Groups 4–6): received 54 mg/kg, 117 mg/kg and 180 mg/kg of the EOT as a pre-treatment and the experimental groups FR (Groups 7–9): received 54 mg/kg,
117 mg/kg and 180 mg/kg of the EOT as a pre-treatment. Value are expressed as mean± SEM (n = 6), Significant difference at P< 0.05 (ANOVA followed by Dunnett’s test)
compared with normal control and ulcer control group, MDA, Malondialdehyde; SOD, superoxide dismutase; CAT, catalase; GSH, reduced glutathione; GPx, glutathione
peroxidase; GST, glutathione transferase; *significant when compared to the ulcer control groups (1 and 2); #significant when compared to the reference control group (3).
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active and/or less active [58].
Conclusion
It may be concluded that a single oral administration of
essential oil from Thymys algeriensis possesses a sig-
nificant gastroprotective effect as assessed by signifi-
cant antioxidant activity as it attenuated the level of
TBARS and elevated levels of GSH, GST, GPx, CATFigure 6 Photomicrography of histological sections of stomach lesion
secretion inside of glands (*) in treated group with EOTa. Female rat (117 m
(c). Microscopy magnification 40 ×.and SOD. This effect could be related to an increase of
gastric mucosal defensive mechanisms. The effective-
ness of the essential oil and its low toxicity requires fur-
ther study to elucidate the action mechanism as well as
to isolate the gastroprotective principles. In addition,
the histopathological results of our study revealed that
treatment with EOTa (117 and 180 mg/kg) resulted in
maintaining the mucosal integrity and a mild mucosal
ulceration.s produced by HCI/ETOH in male and female rats. Note the
g/kg) (a), male rat (180 mg/kg) (b) and female rat (54 mg/kg)
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